Germ cell tumours of the testis

作者: Stefania Gori , Stella Porrozzi , Fausto Roila , Gemma Gatta , Ugo De Giorgi

DOI: 10.1016/J.CRITREVONC.2004.05.006

关键词:

摘要: Abstract Cancer of the testis is a relatively rare disease, accounting for about 1% all cancers in men. Cryptorchidism only confirmed risk factor testicular germ cell tumour. The majority GCT are clinically detectable at initial presentation. Any nodular, hard, or fixed area discovered testis, must be considered neoplastic until proved otherwise. appropriate surgical procedure to make diagnosis radical orchidectomy through an inguinal incision. Many produce tumoural markers (AFP, HCG, LDH), who useful and staging disease; monitor therapeutic response detect tumour recurrence. In 1997 prognostic factor-based classification metastatic tumours was developed by IGCCCG: good, intermediate poor prognosis, with 5-year survival 91, 79 48%, respectively. highly table, often curable, cancer. Germ divided into seminoma non-seminoma types treatment planning because seminomatous more sensitive radiotherapy. Seminoma (all stages combined) has cure rate greater than 90%. For patients low-stage approaches 100%. tumours, >95% I II; it ∼70% standard chemotherapy resection residual if necessary, III IV. Minimum guidelines clinical, biochemical, radiological follow-up have been reported ESMO 2001.

参考文章(179)
Wayne T Spears, James G Morphis II, Steven G Lester, Stephen D Williams, Lawrence H Einhorn, None, Brain metastases and testicular tumors: Long-term survival International Journal of Radiation Oncology*Biology*Physics. ,vol. 22, pp. 17- 22 ,(1992) , 10.1016/0360-3016(92)90977-P
Kamila Czene, Paul Lichtenstein, Kari Hemminki, Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database International Journal of Cancer. ,vol. 99, pp. 260- 266 ,(2002) , 10.1002/IJC.10332
Dean F. Bajorin, Nancy L. Geller, Steven F. Weisen, George J. Bosl, Two-drug therapy in patients with metastatic germ cell tumors Cancer. ,vol. 67, pp. 28- 32 ,(1991) , 10.1002/1097-0142(19910101)67:1<28::AID-CNCR2820670106>3.0.CO;2-3
Carl C. Capelouto, Peter E. Clark, Bernard J. Ransil, Kevin R. Loughlin, A review of scrotal violation in testicular cancer: is adjuvant local therapy necessary? The Journal of Urology. ,vol. 153, pp. 981- 985 ,(1995) , 10.1097/00005392-199503001-00021
Guy C. Toner, George J. Bosl, Sarcoidosis, “sarcoid-like lymphadenopathy,” and testicular germ cell tumors The American Journal of Medicine. ,vol. 89, pp. 651- 656 ,(1990) , 10.1016/0002-9343(90)90185-G
Yvonne D. Senturia, Catherine S. Peckham, Children fathered by men treated with chemotherapy for testicular cancer European Journal of Cancer and Clinical Oncology. ,vol. 26, pp. 429- 432 ,(1990) , 10.1016/0277-5379(90)90010-Q
H. VON DER MAASE, A. GIWERCMAN, J. MÜLLER, N. E. SKAKKEBÆK, Management of carcinoma-in-situ of the testis. International Journal of Andrology. ,vol. 10, pp. 209- 220 ,(1987) , 10.1111/J.1365-2605.1987.TB00186.X
Frederick A. Klein, Marilyn S. Pollack, Pramod C. Sogani, Willet F. Whitmore, Father-son testicular (teratocarcinoma)malignancy Urology. ,vol. 22, pp. 281- 283 ,(1983) , 10.1016/S0090-4295(83)80015-6
L. B. Travis, R. E. Curtis, J. F. Fraumeni, J. D. Boice, H. Storm, M. Andersson, P. Hall, K. Bergfeldt, E. Holowaty, E. A. Clarke, F. E. Van Leeuwen, B. A. Kohler, E. Pukkala, E. Pukkala, T. Wiklund, G. Stoter, M. Gospodarowicz, J. Sturgeon, Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer Journal of the National Cancer Institute. ,vol. 89, pp. 1429- 1439 ,(1997) , 10.1093/JNCI/89.19.1429
J.J. Rassweiler, O. Seemann, T.O. Henkel, C. Stock, T. Frede, P. Alken, Laparoscopic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Tumors: Indications and Limitations The Journal of Urology. ,vol. 156, pp. 1108- 1113 ,(1996) , 10.1016/S0022-5347(01)65718-5